The quest for the mechanism responsible for the cardiovascular benefits of novel antidiabetic agents.

Hernández, DanielleGalán Arriola, CarlosIbáñez, Borja2023-03-132023-03-132023-01REC: CardioClinics. 2023 Jan 58(1):4-6.http://hdl.handle.net/20.500.12105/15611engVoRhttp://creativecommons.org/licenses/by/4.0/The quest for the mechanism responsible for the cardiovascular benefits of novel antidiabetic agents.Atribución 4.0 Internacional5814-6doi.org/10.1016/j.rccl.2022.09.0022605-1575REC: CardioClinics